Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Nathan Saucier

Vascular & Interventional Radiology Kansas City, MO Medical Doctor

NPI 1326249160 CMS profile 196616

1229 W 67Th St, 2Nd Floor, Kansas City, MO 64113

Open in the dashboard

General payments

$13,559

81 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nathan Saucier of Kansas City, MO is reported in the CMS Open Payments database as having received $13,559 across 81 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 81st percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,280 26
2024 General $462 10
2023 General $2,620 12
2022 General $3,299 21
2021 General $2,607 9
2020 General $92 1
2019 General $3,200 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nathan Saucier
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Nathan Saucier were reported at $1,280. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Nathan Saucier Vascular & Interventional Radiology median Middle half National median
2019 $3,200 $422 $125–$1,555 $163
2020 $92 $200 $68–$652 $114
2021 $2,607 $280 $99–$866 $132
2022 $3,299 $433 $137–$1,497 $149
2023 $2,620 $506 $152–$2,019 $160
2024 $462 $556 $175–$1,930 $164
2025 $1,280 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Inari Medical, Inc. $8,319 21 payments
  2. Abbott Laboratories $2,823 17 payments
  3. Boston Scientific Corporation $971 17 payments
  4. Stryker Corporation $534 8 payments
  5. Penumbra, Inc. $403 10 payments
  6. Bard Peripheral Vascular, Inc. $241 2 payments
  7. Terumo Medical Corporation $139 1 payment
  8. Medtronic, Inc. $87 3 payments
  9. DePuy Synthes Sales Inc. $24 1 payment
  10. Alexion Pharmaceuticals, Inc. $16 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,817 68 payments
  2. Travel and Lodging $3,742 10 payments
  3. Consulting Fee $2,600 2 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,400 1 payment
Products named General payments · program years 2019–2025
  1. CT THROMBECTOMY SYSTEM KIT $6,515 17 payments
  2. FLOWTRIEVER CATHETER, S $4,117 25 payments
  3. FlowTriever $3,200 2 payments
  4. ClotTriever $3,200 2 payments
  5. OMNILINK ELITE $2,357 11 payments
  6. General - Embolics $340 5 payments
  7. Indigo System $243 5 payments
  8. General - Interventional Oncology $242 3 payments
  9. SUPERA $197 3 payments
  10. JETI $156 1 payment
  11. Other $1,219 26 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 166 billing codes

Paid by Medicare

$98,417

Medicare's payments for the services billed

Medicare patients

610

Average age 72

Services billed

1,372

328 women, 282 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 51%
Chronic kidney disease 47%
Ischemic heart disease 45%
Diabetes 42%
Heart failure 37%
Depression 33%
Atrial fibrillation 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

81 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record